173 related articles for article (PubMed ID: 37684602)
1. MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma.
Son SM; Yun J; Kim DW; Jung YS; Han SB; Lee YH; Han HS; Woo CG; Lee HC; Lee OJ
BMC Cancer; 2023 Sep; 23(1):843. PubMed ID: 37684602
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma.
Son SM; Yun J; Lee SH; Han HS; Lim YH; Woo CG; Lee HC; Song HG; Gu YM; Lee HJ; Lee OJ
Sci Rep; 2019 Sep; 9(1):11607. PubMed ID: 31474761
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6.
Han HS; Son SM; Yun J; Jo YN; Lee OJ
FEBS Lett; 2014 Oct; 588(20):3744-50. PubMed ID: 25171863
[TBL] [Abstract][Full Text] [Related]
4. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
Du H; Li Y; Sun R; Yuan Y; Sun S; Zhang Y
Thorac Cancer; 2020 Sep; 11(9):2473-2482. PubMed ID: 32648688
[TBL] [Abstract][Full Text] [Related]
5. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity.
Hong KP; Shin MH; Yoon S; Ji GY; Moon YR; Lee OJ; Choi SY; Lee YM; Koo JH; Lee HC; Lee GK; Kim SR; Lee KH; Han HS; Choe KH; Lee KM; Hong JM; Kim SW; Yi JH; Ji HJ; Kim YB; Song HG
Biomaterials; 2015 Oct; 67():32-41. PubMed ID: 26204223
[TBL] [Abstract][Full Text] [Related]
7. MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.
Lu M; Hu C; Wu F; Shu L; Pan Y; Liu X; Liu P; Ma F; Deng C; Huang M
Lung Cancer; 2020 Sep; 147():193-197. PubMed ID: 32731058
[TBL] [Abstract][Full Text] [Related]
8. Circ_0008035 promotes the progression of gastric cancer via the regulation of miR-1256/CEACAM6 axis.
Chu C; Liu X; Zhao Z; Shi Z
Cell Cycle; 2022 May; 21(10):1091-1102. PubMed ID: 35220873
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer.
Liu X; Lv X; Yang Q; Jin H; Zhou W; Fan Q
Technol Cancer Res Treat; 2018 Jan; 17():1533033818758905. PubMed ID: 29495918
[TBL] [Abstract][Full Text] [Related]
10. Delivery of miR-29a improves the permeability of cisplatin by downregulating collagen I expression.
Qin Z; Ma J; Chu X; Guo T; Feng P; Wang M
Biochem Biophys Res Commun; 2024 May; 710():149884. PubMed ID: 38598901
[TBL] [Abstract][Full Text] [Related]
11. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer.
Chen J; Li Q; An Y; Lv N; Xue X; Wei J; Jiang K; Wu J; Gao W; Qian Z; Dai C; Xu Z; Miao Y
Int J Oncol; 2013 Sep; 43(3):877-85. PubMed ID: 23857344
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.
Chiang WF; Cheng TM; Chang CC; Pan SH; Changou CA; Chang TH; Lee KH; Wu SY; Chen YF; Chuang KH; Shieh DB; Chen YL; Tu CC; Tsui WL; Wu MH
Oncogene; 2018 Jan; 37(1):116-127. PubMed ID: 28892050
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
Pandey R; Zhou M; Islam S; Chen B; Barker NK; Langlais P; Srivastava A; Luo M; Cooke LS; Weterings E; Mahadevan D
Sci Rep; 2019 Dec; 9(1):18347. PubMed ID: 31797958
[TBL] [Abstract][Full Text] [Related]
14. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE
Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
[TBL] [Abstract][Full Text] [Related]
15. Study on molecular mechanism of MiRNA-29a in promoting proliferation and invasion of non-small-cell lung cancer by inhibiting MTSS1.
Liu M; Zeng X; Lu YX; Mo YJ; Liao TH; Gan C; Lu XQ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5531-5538. PubMed ID: 30229825
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer.
Lee H; Jang Y; Park S; Jang H; Park EJ; Kim HJ; Kim H
Theranostics; 2018; 8(15):4247-4261. PubMed ID: 30128051
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
18. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Oncogene; 2004 Jan; 23(2):465-73. PubMed ID: 14724575
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS
RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]